CAMK4

Across TCGA pan-cancer cohorts, CAMK4 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated CAMK4 data layer compared with 25 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher CAMK4 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CAMK4 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

LUAD, OV, and PRAD are the cancer types where CAMK4 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	III,IV	0.145	0.690	<.001	36	view →
OV	OS	Median	II,III,IV	0.346	0.843	.003	18	view →
PRAD	DFS	Median	All	0.617	0.886	.027	6	view →
ACC	DFS	Median	All	0.140	0.666	.049	3	view →
SKCM	DFS	Median	All	0.305	0.195	.049	1	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

CAMK4–LUAD (OS)

Open the LUAD breakdown →